Maya Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
- Paid Up Capital ₹ 1.18 Cr
- Company Age 26 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.30 Cr
- Satisfied Charges ₹ 1.70 Cr
- Revenue Growth -29.51%
- Profit Growth -44.62%
- Ebitda -46.67%
- Net Worth 29.67%
- Total Assets 47.92%
About Maya Biotech
Maya Biotech Private Limited (MBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 15 May 1998 and has a history of 26 years and eight months. Its registered office is in Chandigarh, India.
The Corporate was formerly known as Toshika Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.18 Cr.
The company currently has active open charges totaling ₹3.30 Cr. The company has closed loans amounting to ₹1.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manoj Agarwal and Parth Agarwal serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U55101CH1998PTC021391
-
Company No.
021391
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 May 1998
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Maya Biotech Private Limited offer?
Maya Biotech Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Common Disease Medicines, Eye Drops, Anti Infective Drugs & Medicines, Antibiotic Injection, Antibiotic Tablets, Capsule & Syrup, IV Fluids, Sexual Wellness Products, Fertility Enhancer.
Who are the key members and board of directors at Maya Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parth Agarwal
|
Director | 10-Oct-2019 | Current |
|
Manoj Agarwal
|
Whole-Time Director | 14-May-2012 | Current |
Financial Performance of Maya Biotech.
Maya Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 29.51% decrease. The company also saw a substantial fall in profitability, with a 44.62% decrease in profit. The company's net worth Soared by an impressive increase of 29.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maya Biotech?
In 2023, Maya Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Carelife Foods Private LimitedManoj Agarwal is a mutual person
-
Coro Safe Private Limited
Manoj Agarwal is a mutual person
-
Mediaid Labs Private Limited
Manoj Agarwal is a mutual person
Charges (Loans)
₹3.30 Cr
₹1.70 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 2.80 Cr
- Others : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Aug 2024 | Others | ₹5.00 M | Open |
| 16 Feb 2013 | Axis Bank Limited | ₹1.90 Cr | Open |
| 02 Feb 2013 | Axis Bank Limited | ₹5.50 M | Open |
| 02 Feb 2013 | Axis Bank Limited | ₹3.50 M | Open |
| 30 May 2011 | Uco Bank | ₹1.00 Cr | Satisfied |
How Many Employees Work at Maya Biotech?
Maya Biotech has a workforce of 53 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maya Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maya Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
